Head-to-head · Cost-Efficiency Index
Medical Health Institute vs SexyMD
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Medical Health Institute
Shoppers comparing across TRT, peptides, and weight loss under one provider who don't need public pricing detail up front.
Visit Medical Health InstituteSexyMD
Readers willing to commit 48 weeks up front, where the advertised figure is the one actually charged.
Visit SexyMDThe verdict
Medical Health Institute and SexyMD tie on the Cost-Efficiency Index at 68/100, so neither wins outright on the numbers. For most shoppers we'd start with Medical Health Institute (ranked #116, a hair above #119) — Shoppers comparing across TRT, peptides, and weight loss under one provider who don't need public pricing detail up front. But SexyMD is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Medical Health Institute.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Medical Health Institute | SexyMD |
|---|---|---|
| Cost-Efficiency Index | 68/100 | 68/100 |
| Semaglutide / mo | $100/mo (all doses, compounded) | $269/mo on the four-week plan (the site's "from $199" is the 48-week commitment rate) |
| Tirzepatide / mo | Not disclosed | $369/mo on the four-week plan (the site's "from $299" is the 48-week commitment rate) |
| Semaglutide / yr (modeled) | $1,200 | $3,228 |
| Tirzepatide / yr (modeled) | — | $4,428 |
| Coverage | Coverage not published | 47 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #116 | #119 |
Medical Health Institute
68/100Where the value is
- Advertises a competitively low $100/mo entry price for GLP-1 weight loss
- Offers multiple service lines (weight loss, TRT, peptide therapy) under one provider
- LegitScript and HIPAA-compliance badges both displayed on the homepage
The tradeoffs
- The $100/mo headline price carries the company's own asterisk — '*Based on pharmacy availability' — meaning it is explicitly not a guaranteed rate before intake
- No dose tier or even which drug (semaglutide vs. tirzepatide) the $100 figure applies to is disclosed anywhere public
SexyMD
68/100Where the value is
- Publishes a full four-rung price table for each molecule on its product pages, before any intake
- States both pharmacy classes it uses and discloses that a prescription may be routed to, and transferred between, any pharmacy in that network
- Names the professional entities its prescribers work through, rather than referring only to licensed providers
The tradeoffs
- Every headline on the site quotes the 48-week rate: "from $199 per month" against a four-week price of $269, and "from $299" against $369, with an asterisk that resolves to no footnote
- The same footer block says both "available in all 50 states" and "available in all states except Arkansas, Mississippi, and New Jersey", on all eleven pages
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.